Novo Nordisk is working on a new ... drug, CagriSema, combines semaglutide with another medicine called cagrilintide. The ...
Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...
Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback